Blogs

Complacent or Overly Compliant? Why Has Industry Been Slow to Adopt Single-Use for Bioprocess Control?

Wyeth's OpEx Legacy

Change: It’s Coming (or “I’ll Get Agile… Mañana”)

Go Out and Gemba

Pfizer Reveals Details of Wyeth-Infused Corporate Structure

Pfizer-Wyeth: The Blockbuster Model's Latest Monster?

BIO 2008: Quality by Design Needs Champions